LUNGevity Foundation and Oncogene Cancer Research are joining up with 23andMe to advance lung cancer research

Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post by Oncogene Cancer Research, on X:

“LUNGevity Foundation is is also part of this study led by 23andMe to learn more about the genetics of lung cancer and how that may inform early detection, treatment and more.”

Quoting Oncogene Cancer Research‘s post:

“We’re joining up with 20+ advocacy organisations and 23andMe to advance lung cancer research. Open to people 18+ diagnosed with lung cancer and living in the US. Learn more about how your genetics could help fuel treatment discoveries and enrol in our study.”

Read further.
Source: Amy C. Moore/X and Oncogene Cancer Research/X